Cargando…
Understanding Non-Mendelian Genetic Risk
This opinion paper highlights strategies for a better understanding of non-Mendelian genetic risk that was revealed by genome-wide association studies (GWAS) of complex diseases. The genetic risk resides predominantly in non-coding regulatory DNA, such as in enhancers. The identification of mechanis...
Autor principal: | Coetzee, Gerhard A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235392/ https://www.ncbi.nlm.nih.gov/pubmed/32476988 http://dx.doi.org/10.2174/1389202920666191018085511 |
Ejemplares similares
-
Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer
por: Jarvis, David, et al.
Publicado: (2016) -
The next step in Mendelian randomization
por: Weith, Matthias, et al.
Publicado: (2023) -
Glucocorticoids unmask silent non-coding genetic risk variants for common diseases
por: Nguyen, Thanh Thanh L, et al.
Publicado: (2022) -
Genome-wide Runx2 occupancy in prostate cancer cells suggests a role in regulating secretion
por: Little, Gillian H., et al.
Publicado: (2012) -
Genetically Determined Plasma Lipid Levels and Risk of Diabetic Retinopathy: A Mendelian Randomization Study
por: Sobrin, Lucia, et al.
Publicado: (2017)